Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
22024 | 396 | 38.8 | 89% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
603 | 3 | HUNTINGTONS DISEASE//SPINOCEREBELLAR ATAXIA//POLYGLUTAMINE | 14359 |
3956 | 2 | RKIP//RAF KINASE INHIBITOR PROTEIN//HIPPOCAMPAL CHOLINERGIC NEUROSTIMULATING PEPTIDE | 753 |
22024 | 1 | RKIP//RAF KINASE INHIBITOR PROTEIN//HIPPOCAMPAL CHOLINERGIC NEUROSTIMULATING PEPTIDE | 396 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | RKIP | authKW | 4844392 | 21% | 74% | 85 |
2 | RAF KINASE INHIBITOR PROTEIN | authKW | 2552918 | 9% | 95% | 35 |
3 | HIPPOCAMPAL CHOLINERGIC NEUROSTIMULATING PEPTIDE | authKW | 1084339 | 4% | 94% | 15 |
4 | PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN | authKW | 1045891 | 6% | 59% | 23 |
5 | PEBP | authKW | 1012920 | 4% | 77% | 17 |
6 | RAF KINASE INHIBITORY PROTEIN | authKW | 642569 | 3% | 83% | 10 |
7 | RAF KINASE INHIBITOR PROTEIN RKIP | authKW | 624578 | 2% | 90% | 9 |
8 | PEBP4 | authKW | 539761 | 2% | 100% | 7 |
9 | HCNP | authKW | 480441 | 2% | 69% | 9 |
10 | HIPPOCAMPAL CHOLINERGIC NEUROSTIMULATING PEPTIDE PRECURSOR PROTEIN | authKW | 472289 | 2% | 88% | 7 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 1251 | 30% | 0% | 119 |
2 | Biochemistry & Molecular Biology | 469 | 31% | 0% | 123 |
3 | Cell Biology | 464 | 19% | 0% | 75 |
4 | Pathology | 206 | 7% | 0% | 28 |
5 | Neurosciences | 111 | 12% | 0% | 48 |
6 | Biophysics | 92 | 7% | 0% | 26 |
7 | Biochemical Research Methods | 46 | 5% | 0% | 18 |
8 | Medicine, Research & Experimental | 32 | 5% | 0% | 18 |
9 | Developmental Biology | 26 | 2% | 0% | 8 |
10 | Genetics & Heredity | 18 | 4% | 0% | 17 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CANC BIOL BIOCHEM | 86744 | 1% | 38% | 3 |
2 | BIOCHEM CANC BIOL | 79785 | 5% | 6% | 18 |
3 | BEN MAY CANC CANC | 77109 | 0% | 100% | 1 |
4 | HERBAL PHARMACOL ORIENTAL MED | 77109 | 0% | 100% | 1 |
5 | HLTH SCI MOTHER CHILD CARE G DALESSANDRO | 77109 | 0% | 100% | 1 |
6 | IST BIOSTRUTTUE BIOIMMAGINI | 77109 | 0% | 100% | 1 |
7 | MED ONTOL | 77109 | 0% | 100% | 1 |
8 | NAT SCI WELLNESS | 77109 | 0% | 100% | 1 |
9 | NEUROIOL PHARMACOL PHYSIOL | 77109 | 0% | 100% | 1 |
10 | NEUROSURG REPAIR | 77109 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | TUMOR BIOLOGY | 2806 | 4% | 0% | 15 |
2 | PATHOLOGY & ONCOLOGY RESEARCH | 539 | 1% | 0% | 3 |
3 | CANCER BIOMARKERS | 498 | 1% | 0% | 2 |
4 | CRITICAL REVIEWS IN IMMUNOLOGY | 497 | 1% | 0% | 2 |
5 | DEVELOPMENTAL NEUROSCIENCE | 441 | 1% | 0% | 3 |
6 | OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY | 436 | 1% | 0% | 2 |
7 | ONCOTARGET | 389 | 2% | 0% | 8 |
8 | CELL DIVISION | 372 | 0% | 0% | 1 |
9 | MEDICAL ONCOLOGY | 369 | 1% | 0% | 4 |
10 | CLINICAL & EXPERIMENTAL METASTASIS | 342 | 1% | 0% | 3 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | AL-MULLA, F , BITAR, MS , TAQI, Z , YEUNG, KC , (2013) RKIP: MUCH MORE THAN RAF KINASE INHIBITORY PROTEIN.JOURNAL OF CELLULAR PHYSIOLOGY. VOL. 228. ISSUE 8. P. 1688-1702 | 102 | 57% | 33 |
2 | RAJKUMAR, K , NICHITA, A , ANOOR, PK , RAJU, S , SINGH, SS , BURGULA, S , (2016) UNDERSTANDING PERSPECTIVES OF SIGNALLING MECHANISMS REGULATING PEBP1 FUNCTION.CELL BIOCHEMISTRY AND FUNCTION. VOL. 34. ISSUE 6. P. 394 -403 | 50 | 77% | 0 |
3 | ESCARA-WILKE, J , YEUNG, K , KELLER, ET , (2012) RAF KINASE INHIBITOR PROTEIN (RKIP) IN CANCER.CANCER AND METASTASIS REVIEWS. VOL. 31. ISSUE 3-4. P. 615 -620 | 41 | 85% | 19 |
4 | MARTINHO, O , PINTO, F , GRANJA, S , MIRANDA-GONCALVES, V , MOREIRA, MAR , RIBEIRO, LFJ , DI LORETO, C , ROSNER, MR , LONGATTO, A , REIS, RM , (2013) RKIP INHIBITION IN CERVICAL CANCER IS ASSOCIATED WITH HIGHER TUMOR AGGRESSIVE BEHAVIOR AND RESISTANCE TO CISPLATIN THERAPY.PLOS ONE. VOL. 8. ISSUE 3. P. - | 43 | 78% | 12 |
5 | ZENG, LC , IMAMOTO, A , ROSNER, MR , (2008) RAF KINASE INHIBITORY PROTEIN (RKIP): A PHYSIOLOGICAL REGULATOR AND FUTURE THERAPEUTIC TARGET.EXPERT OPINION ON THERAPEUTIC TARGETS. VOL. 12. ISSUE 10. P. 1275 -1287 | 61 | 56% | 66 |
6 | AFONSO, J , LONGATTO, A , MARTINHO, O , LOBO, F , AMARO, T , REIS, RM , SANTOS, LL , (2013) LOW RKIP EXPRESSION ASSOCIATES WITH POOR PROGNOSIS IN BLADDER CANCER PATIENTS.VIRCHOWS ARCHIV. VOL. 462. ISSUE 4. P. 445-453 | 40 | 77% | 4 |
7 | MARTINHO, O , GRANJA, S , JARAQUEMADA, T , CAEIRO, C , MIRANDA-GONCALVES, V , HONAVAR, M , COSTA, P , DAMASCENO, M , ROSNER, MR , LOPES, JM , ET AL (2012) DOWNREGULATION OF RKIP IS ASSOCIATED WITH POOR OUTCOME AND MALIGNANT PROGRESSION IN GLIOMAS.PLOS ONE. VOL. 7. ISSUE 1. P. - | 33 | 79% | 16 |
8 | TAVEL, L , JAQUILLARD, L , KARSISIOTIS, AI , SAAB, F , JOUVENSAL, L , BRANS, A , DELMAS, AF , SCHOENTGEN, F , CADENE, M , DAMBLON, C , (2012) LIGAND BINDING STUDY OF HUMAN PEBP1/RKIP: INTERACTION WITH NUCLEOTIDES AND RAF-1 PEPTIDES EVIDENCED BY NMR AND MASS SPECTROMETRY.PLOS ONE. VOL. 7. ISSUE 4. P. - | 32 | 76% | 7 |
9 | MARTINHO, O , SIMOES, K , LONGATTO, A , JACOB, CE , ZILBERSTEIN, B , BRESCIANI, C , GAMA-RODRIGUES, J , CECCONELLO, I , ALVES, V , REIS, RM , (2013) ABSENCE OF RKIP EXPRESSION IS AN INDEPENDENT PROGNOSTIC BIOMARKER FOR GASTRIC CANCER PATIENTS.ONCOLOGY REPORTS. VOL. 29. ISSUE 2. P. 690-696 | 33 | 72% | 3 |
10 | NIE, F , CAO, JG , TONG, JL , ZHU, MM , GAO, Y , RAN, ZH , (2015) ROLE OF RAF-KINASE INHIBITOR PROTEIN IN COLORECTAL CANCER AND ITS REGULATION BY HYDROXYCAMPTOTHECINE.JOURNAL OF BIOMEDICAL SCIENCE. VOL. 22. ISSUE . P. - | 27 | 79% | 4 |
Classes with closest relation at Level 1 |